Case report: Clinical and molecular features of renal gastrointestinal tumor

While gastrointestinal stromal tumors (GISTs) often arise within the GI tract, it is well known that GISTs may also rarely emanate outside of the digestive system. Prior case reports have documented various primary sites in non-GI organs [extra-intestinal GIST (EGIST)], yet only one report has described a localized GIST of renal origin. Here, we describe a patient who presented with bilateral renal masses who was found to have a large unresectable renal GIST tumor treated with imatinib. We discuss treatment experience and response with systemic therapy and describe molecular data to contextualize this ultra-rare presentation within the landscape of EGIST tumors.

Authors

Institutions

Publication Details

Journal
Frontiers in Oncology
Published
2025-02-13
DOI
https://doi.org/10.3389/fonc.2025.1508600
Primary Topic
Gastrointestinal Tumor Research and Treatment
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Case report: Clinical and molecular features of renal gastrointestinal tumor

Guido Dalbagni, Rayan Rammal, Ritesh R. Kotecha, Hikmat A Al‐Ahmadie et al.
Frontiers in Oncology
Gastrointestinal Tumor Research and Treatment
article

Case report: Clinical and molecular features of renal gastrointestinal tumor

Guido Dalbagni, Rayan Rammal, Ritesh R. Kotecha, Hikmat A Al‐Ahmadie, Narasimhan P. Agaram, Gopa Iyer, Ping Gu, S. P. Makker
article en

Abstract

While gastrointestinal stromal tumors (GISTs) often arise within the GI tract, it is well known that GISTs may also rarely emanate outside of the digestive system. Prior case reports have documented various primary sites in non-GI organs [extra-intestinal GIST (EGIST)], yet only one report has described a localized GIST of renal origin. Here, we describe a patient who presented with bilateral renal masses who was found to have a large unresectable renal GIST tumor treated with imatinib. We discuss treatment experience and response with systemic therapy and describe molecular data to contextualize this ultra-rare presentation within the landscape of EGIST tumors.

Frontiers in OncologyVol. 15
Memorial Sloan Kettering Cancer Center (US)
U.S. Department of Defense, National Institutes of Health, National Cancer Institute
Good health and well-being
Openalex Percentile: Top 96%
Gastrointestinal Tumor Research and Treatment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.